A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/19 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 31/198 (2006.01) A61K 31/205 (2006.01)
Patent
CA 2413816
A sustained release formulation of L-arginine alone or in combination with an agent which enhances the biotransformation of L-arginine into NO is described herein. Figure 1A shows a schematic representation of proposed L-arginine dependent and independent pahtways.
L'invention concerne une formulation à libération lente de L-arginine seule ou combinée à un agent qui renforce la biotransformation de la L-arginine en NO. La figure 1A montre une représentation schématique de trajectoires proposées dépendantes et indépendantes de L-arginine.
Angiogenix Inc.
Borden Ladner Gervais Llp
LandOfFree
Controlled release arginine formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release arginine formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release arginine formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1641730